Author:
Zhang Jianxiu,Yuan Yongxue,Gao Xiaoyan,Li Hui,Yuan Fengxia,Wu Di,Cui Qinglong,Piao Guangchun,Yuan Haidan
Reference51 articles.
1. Non-alcoholic fatty liver disease: Current therapeutic options;A Majumdar;Curr. Opin. Pharmacol,2021
2. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner;X Han;Chem. Biol. Interact,2019
3. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-?1/Smad2, NF-?B, and AMPK signaling;G Liu;Phytother. Res,2021
4. Involvement of HO-1 and autophagy in the protective effect of magnolol in hepatic steatosis-induced NLRP3 inflammasome activation in vivo and in vitro;N C Kuo;Antioxidants (Basel),2020